Thorax 69:386 doi:10.1136/thoraxjnl-2013-204476
  • PostScript
  • Correspondence

SKUP3 trial: comment

  1. Malcolm Kohler2
  1. 1 Oxford Centre for Respiratory Medicine, Oxford University, Churchill Hospital Campus, Oxford, UK
  2. 2 Division of Pulmonology, University Hospital Zurich, Zurich, Switzerland
  1. Correspondence to Professor J Stradling, Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford OX3 7LJ, UK; john.stradling{at}
  • Received 4 September 2013
  • Accepted 3 October 2013
  • Published Online First 21 October 2013

The paper on uvulopalatopharyngoplasty (the SKUP3 trial, September 2013 issue of Thorax) is a significant contribution to the literature on the surgical management of obstructive sleep apnea (OSA).1 The authors are to be congratulated on pushing through such a difficult trial with good control subjects. However, there is one concern that we have, which may alter the clinical conclusions that should be drawn. Patients for this trial were …